Oxford-AstraZeneca’s Covishield vaccine cleared by expert panel

In a step closer towards India approving its first coronavirus vaccine, the Subject Expert Committee of the Central Drug Standard Control Organisation on Friday recommended emergency use of Oxford-AstraZeneca’s ‘Covishield’ vaccine.

The application will be sent to Drugs Controller General of India (DCGI) V.G. Somani for final approval.

The expert panel had convened a meeting on Friday afternoon to take a call on the emergency use authorisation sought by the Serum Institute of India, which is Covishield’s manufacturer, and Bharat Biotech for their coronavirus vaccine candidates.

A decision on Bharat Biotech’s Covaxin was still awaited at the meeting which is still underway, the Health Ministry said.

Read More: https://www.bhaskarlive.in/oxford-astrazenecas-covishield-vaccine-cleared-by-expert-panel-lead/